Acquired idiopathic sideroblastic anemia

What it is

From: Orphanet

A rare myelodysplastic syndrome (MDS) characterized by ineffective hemopoiesis affecting one or more blood cell lineages (myeloid, erythroid or megakaryocytic) leading to peripheral blood cytopenias and an increased risk of developing leukaemia.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Anemia of inadequate production · Very frequent (99-80%)

A kind of anemia characterized by inadequate production of erythrocytes.

Refractory anemia with ringed sideroblasts · Very frequent (99-80%)

A type of myelodysplastic syndrome characterized by less than 5% myeloblasts in the bone marrow, but with 15% or greater red cell precursors in the marrow being abnormal iron-stuffed cells called ringed sideroblasts.

Erythroid hyperplasia · Frequent (79-30%)

Increased count of erythroid precursor cells, that is, erythroid lineage cells in the bone marrow.

Normocytic anemia · Frequent (79-30%)

A kind of anemia in which the volume of the red blood cells is normal.

Pallor · Frequent (79-30%)

Abnormally pale skin.

Megaloblastic erythroid hyperplasia · Frequent (79-30%)

Normochromic anemia · Frequent (79-30%)

Abnormal fingernail morphology · Occasional (29-5%)

An abnormality of the fingernails.

Abnormal megakaryocyte morphology · Occasional (29-5%)

Any structural anomaly of megakaryocytes. Mature blood platelets are released from the cytoplasm of megakaryocytes, which are bone-marrow resident cells.

Chronic infection · Occasional (29-5%)

Presence of a protracted or persistent infection by a pathogen potentially related to an underlying abnormality of the immune system that is not able to clear the infection.

Hepatomegaly · Occasional (29-5%)

Abnormally increased size of the liver.

Hypochromic anemia · Occasional (29-5%)

A type of anemia characterized by an abnormally low concentration of hemoglobin in the erythrocytes.

Hyposegmentation of neutrophil nuclei · Occasional (29-5%)

Hyposegmented (hypolobulated) or bilobed neutrophil nuclei.

Myelodysplasia · Occasional (29-5%)

Clonal hematopoietic stem cell disorders characterized by dysplasia (ineffective production) in one or more hematopoietic cell lineages, leading to anemia and cytopenia.

Other findings in the same source

From: Orphanet

Additional reported features include Splenomegaly (Occasional (29-5%)); Thrombocytopenia (Occasional (29-5%)); Abnormal number of granulocyte precursors (Occasional (29-5%)); Dysplastic granulopoesis (Occasional (29-5%)); Abnormal bleeding (Very rare (<4-1%)); Acute myeloid leukemia (Very rare (<4-1%)); Bone marrow hypocellularity (Very rare (<4-1%)); Congestive heart failure (Very rare (<4-1%)); Decreased total neutrophil count (Very rare (<4-1%)); Granulocytopenia (Very rare (<4-1%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

Adult

Inheritance in the source

From: Orphanet

Not applicable

Frequency and the population described

From: Orphanet

Annual incidence: <1 / 1 000 000; Europe; Value and class.

Which doctor should you see?

The suggested department for discussing Acquired idiopathic sideroblastic anemia is Haematology, with a haematologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Which blood-cell, marrow, bleeding or clotting finding matters most?
• Does the diagnosis need confirmation or a more precise subtype?
• Which symptoms or laboratory changes should trigger earlier review?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Acquired idiopathic sideroblastic anemia. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.